Agenus Inc. (AGEN)

Agenus Market Cap

Agenus has a market cap or net worth of $126.18 million as of June 26, 2026. Its market cap has decreased by -10.83% in one year.

• Market Cap: 126.18M
• Enterprise Value: 131.42M
• 1-Year Change: -10.83%
• Ranking: #4186
• Category: Micro-Cap
• Stock Price: $3.03

Market Cap Chart

Since February 8, 2000, Agenus's market cap has decreased from $1.10B to $126.18M, a decrease of -88.50%. That is a compound annual growth rate of -7.87%.

Market Cap History

Date	Market Cap	% Change
Jun 26, 2026	126.18M	18.14%
Dec 31, 2025	106.80M	66.10%
Dec 31, 2024	64.30M	-79.64%
Dec 29, 2023	315.80M	-56.83%
Dec 30, 2022	731.50M	-11.55%
Dec 31, 2021	827.00M	36.76%
Dec 31, 2020	604.70M	8.16%
Dec 31, 2019	559.10M	95.76%
Dec 31, 2018	285.60M	-12.55%
Dec 29, 2017	326.60M	-9.03%
Dec 30, 2016	359.00M	-6.58%
Dec 31, 2015	384.30M	54.40%
Dec 31, 2014	248.90M	165.92%
Dec 31, 2013	93.60M	-7.14%
Dec 31, 2012	100.80M	134.97%
Dec 30, 2011	42.90M	-57.23%
Dec 31, 2010	100.30M	74.74%
Dec 31, 2009	57.40M	80.50%
Dec 31, 2008	31.80M	-67.22%
Dec 31, 2007	97.00M	15.61%
Dec 29, 2006	83.90M	-61.34%
Dec 30, 2005	217.00M	-52.90%
Dec 31, 2004	460.70M	2.90%
Dec 31, 2003	447.70M	32.18%
Dec 31, 2002	338.70M	-28.80%

View and export this data all the way back to 2000. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jun 25, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Jun 26, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Jyong Biotech	129.17M
NRx Pharmaceuticals	128.86M
Genelux	126.79M
Coya Therapeutics	124.79M
Fractyl Health	122.95M
PepGen	122.43M
Spero Therapeutics	121.59M
NeOnc Technologies Holdings	120.25M